Nelfinavir Mesylate in Treating Patients With Recurrent, Metastatic, or Unresectable Liposarcoma

NCT00233948 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

TERMINATED

Status

29

Enrollment

OTHER

Sponsor class

Stopped Drug availability issues

Conditions

Adult Liposarcoma
Recurrent Adult Soft Tissue Sarcoma
Stage III Adult Soft Tissue Sarcoma
Stage IV Adult Soft Tissue Sarcoma

Interventions

DRUG: nelfinavir mesylate
PROCEDURE: biopsy
OTHER: laboratory biomarker analysis
OTHER: pharmacological study
GENETIC: gene expression analysis
GENETIC: western blotting
GENETIC: reverse transcriptase-polymerase chain reaction
OTHER: immunoenzyme technique

Sponsor

City of Hope Medical Center